ImmuCell Corporation operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ImmuCell with three other
pharmaceutical manufacturers in North America:
Epicore Bionetworks Incorporated
sales of 12.49 million Canadian Dollars [US$9.53 million]
Aviragen Therapeutics Inc
of which 100%
was Antibody Products), and
Canopy Growth Corp
based in Canada
(12.70 million Canadian Dollars [US$9.69 million]
During the year ended December of 2016, sales at
ImmuCell were $9.54 million.
decrease of 6.7%
versus 2015, when the company's sales were $10.23 million.